Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Cell-cell fusion and immunostimulatory cytokines significantly impact oncolytic vaccinia virus immunotherapeutic potentialMotomu Nakatake, Hana Itadani, Hajime Kurosaki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2020
Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironmentMotomu Nakatake, Nozomi Kuwano, Emi Kaitsurumaru, et al.
Experimental Animals|November 10, 2009
Effects of Tritrichomonas muris on the mouse intestine: a proteomic analysisAkiko Kashiwagi, Hajime Kurosaki, Hong Luo, et al.
Biochemical and Biophysical Research Communications|July 3, 2019
Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancerKosuke Horita, Hajime Kurosaki, Motomu Nakatake, et al.
Biochemical and Biophysical Research Communications|January 8, 2013
An induced pluripotent stem cell-mediated and integration-free factor VIII expression systemYuwna Yakura, Chie Ishihara, Hajime Kurosaki, et al.
Molecular Therapy Oncolytics|June 26, 2019
Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic FunctionMotomu Nakatake, Hajime Kurosaki, Nozomi Kuwano, et al.
Biochemical and Biophysical Research Communications|December 26, 2006
A comparison study in the proteomic signatures of multipotent germline stem cells, embryonic stem cells, and germline stem cellsHajime Kurosaki, Yasuhiro Kazuki, Masaharu Hiratsuka, et al.
Pageof 2